{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:01:45Z","timestamp":1768518105058,"version":"3.49.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,3]],"date-time":"2015-07-03T00:00:00Z","timestamp":1435881600000},"content-version":"vor","delay-in-days":367,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005285","name":"Fapeg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005285","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.vaccine.2014.06.037","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T02:45:43Z","timestamp":1403145943000},"page":"4324-4332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection"],"prefix":"10.1016","volume":"32","author":[{"given":"Monalisa Martins","family":"Trentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1bio Muniz","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilisa Pedroso","family":"Nogueira Gaeti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline Carvalho","family":"Batista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana Martins","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Kipnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Junqueira-Kipnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.06.037_bib0005","series-title":"WHO report","article-title":"The global plan to stop TB 2011\u20132015","author":"WHO","year":"2012"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0010","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S1472-9792(12)70005-7","article-title":"Tuberculosis vaccines: a strategic blueprint for the next decade","volume":"92","author":"Brennan","year":"2012","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0015","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculosis meningitis and military tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2012.03.004","article-title":"Tuberculosis vaccine development: strength lies in tenacity","volume":"7","author":"Kaufmann","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1128\/CMR.18.4.687-702.2005","article-title":"Vaccines for tuberculosis: novel concepts and recent progress","volume":"18","author":"Doherty","year":"2005","journal-title":"Clin Microb Rev"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/0952-7915(95)80096-4","article-title":"The protective immune response to Mycobacterium tuberculosis","volume":"4","author":"Cooper","year":"1995","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0035","doi-asserted-by":"crossref","first-page":"e47781","DOI":"10.1371\/journal.pone.0047781","article-title":"Immunogenicity of a fusion protein containing immunodominant epitopes of Ag85C. MPT51, and HspX from Mycobacterium tuberculosis in mice and active TB infection","volume":"7","author":"de Sousa","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0040","doi-asserted-by":"crossref","first-page":"e83884","DOI":"10.1371\/journal.pone.0083884","article-title":"A dual TLR agoinst adjuvant enhances the immunogenicity and protective efficacy of the tuberculosis vaccine antigen ID93","volume":"1","author":"Orr","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fimmu.2014.00152","article-title":"Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memory","volume":"5","author":"da Costa","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0050","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine. Mtb72F, delivered as naked DNA or recombinant protein","volume":"12","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.4161\/hv.8570","article-title":"The candidate tuberculosis vaccine Mtb72F\/AS02A: tolerability and immunogenicity in humans","volume":"7","author":"von Eschen","year":"2009","journal-title":"Hum Vaccines"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0060","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.vaccine.2006.03.072","article-title":"Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31","volume":"26","author":"Agger","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0065","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1016\/j.vaccine.2006.03.071","article-title":"IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses","volume":"26","author":"Schellack","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0070","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B\u2013ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0080","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/CVI.00111-09","article-title":"Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa","volume":"8","author":"Black","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/IAI.01137-06","article-title":"Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice","volume":"2","author":"Roupie","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0090","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.vaccine.2013.11.065","article-title":"Immunogenic potencial of latency associated antigens against Mycobacterium tuberculosis","volume":"6","author":"Singh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/1040841X.2011.606425","article-title":"Understanding the biology of 16kDa antigen of Mycobcterium tuberculosis: scope in diagnosis, vaccine design and therapy","volume":"37","author":"Siddiqui","year":"2011","journal-title":"Crit Rev Microb"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/bbug.1.1.10027","article-title":"In vivo persistence and protective efficacy of the bacilli Calmette Guerin vaccine overexpressing the HspX latency antigen","volume":"1","author":"Spratt","year":"2010","journal-title":"Bioeng Bugs"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0105","doi-asserted-by":"crossref","first-page":"e23360","DOI":"10.1371\/journal.pone.0023360","article-title":"A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against Tuberculosis","volume":"6","author":"Dey","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0110","first-page":"01","article-title":"HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule","volume":"00","author":"Taylor","year":"2012","journal-title":"Immun Cell Biol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0115","doi-asserted-by":"crossref","first-page":"7513","DOI":"10.1016\/j.vaccine.2012.10.045","article-title":"A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice","volume":"52","author":"Geluk","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0120","first-page":"771","article-title":"Diagnostic potential of 16kDa (HspX, \u03b1-crystalline) antigen for serodiagnosis of tuberculosis","volume":"5","author":"Kaushik","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0125","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1590\/S1413-86702011000600022","article-title":"Role of antibodies reactive to HspX in discriminating pulmonary tuberculosis contacts with high risk of developing active disease","volume":"6","author":"Reis","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1574-695X.2010.00660.x","article-title":"The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants","volume":"59","author":"Chen","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-3083.2011.02531.x","article-title":"Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice","volume":"73","author":"Li","year":"2011","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0140","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.vaccine.2011.10.032","article-title":"Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX","volume":"29","author":"Niu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0145","doi-asserted-by":"crossref","first-page":"7914","DOI":"10.1073\/pnas.1104588108","article-title":"Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8T cells","volume":"108","author":"MacLeod","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"4","author":"Bode","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0155","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"20","author":"Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0160","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cord factor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"9","author":"Agger","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.imbio.2006.05.021","article-title":"Targeting antigens to dendritic cells in vivo","volume":"211","author":"Tacken","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nmat2960","article-title":"Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses","volume":"10","author":"Moon","year":"2011","journal-title":"Nat Mater"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0175","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/jps.22427","article-title":"Subunit vaccines: distearoyl phosphatidyl choline-based liposomes entrapping antigen offer a neutral alternative to dimethyl dioctadecyl ammonium-based cationic liposomes as an adjuvant delivery system","volume":"100","author":"McNeil","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0180","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.4049\/jimmunol.161.8.4000","article-title":"Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen","volume":"8","author":"Brewer","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0185","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.4049\/jimmunol.173.10.6143","article-title":"Vesicle\u00a0size influences the trafficking, processing, and presentation of antigens in lipid vesicles","volume":"10","author":"Brewer","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2011.05.019","article-title":"The vesicle size of DDA:TDB liposomal adjuvants plays a role in the cell-mediated immune response but has no significant effect on antibody production","volume":"154","author":"Henriksen-Lacey","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0195","unstructured":"Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratory. http:\/\/www.cvmbs.colostate.edu\/mip\/tb\/pdf\/RP021.pdf."},{"key":"10.1016\/j.vaccine.2014.06.037_bib0200","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.bb.09.060180.002343","article-title":"Comparative properties and methods of preparation of lipid vesicles (liposomes)","volume":"9","author":"Szoka","year":"1980","journal-title":"Annu Rev Biophys Bioeng"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0205","doi-asserted-by":"crossref","first-page":"e78639","DOI":"10.1371\/journal.pone.0078639","article-title":"Prime-Boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis","volume":"11","author":"Junqueira-Kipnis","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0210","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/S0264-410X(03)00220-2","article-title":"Growth phase of orally administered Lactobacillus strains differentially affects IgG1\/IgG2a ratio for soluble antigens: implications for vaccine development","volume":"21","author":"Maassen","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0215","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0220","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0225","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.micinf.2010.11.002","article-title":"The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis","volume":"13","author":"Jeon","year":"2011","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0230","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/JB.180.4.801-808.1998","article-title":"Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton a-crystallin homolog","volume":"180","author":"Cunningham","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0235","doi-asserted-by":"crossref","first-page":"e61681","DOI":"10.1371\/journal.pone.0061681","article-title":"Differential and site specific impact of B cells in the protective immune response to Mycobacterium tuberculosis in the mouse","volume":"4","author":"Torrado","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0240","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0531-5565(00)00257-6","article-title":"The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4","volume":"36","author":"Turner","year":"2001","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0245","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.4049\/jimmunol.178.11.7222","article-title":"B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis","volume":"178","author":"Maglione","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0250","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.4049\/jimmunol.1200994","article-title":"CD4+ T cell-dependent IFN-\u03b3 production by CD8+ effector T cells in Mycobacterium tuberculosis infection","volume":"5","author":"Bold","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0255","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0260","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1016\/j.vaccine.2009.05.049","article-title":"MPT-51\/CpG DNA vaccine protects mice against Mycobacterium tuberculosis","volume":"27","author":"Silva","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0265","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.5588\/ijtld.12.0479","article-title":"The knowns and unknowns of the immunopathogenesis of tuberculosis","volume":"11","author":"Ottenhoff","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0270","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4614-6111-1_8","article-title":"Antigen-Specific CD8+ T cells and protective immunity to tuberculosis","volume":"783","author":"Behar","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0275","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.177.3.1780","article-title":"memory and effector human CD8T cells phenotypical and functional analysis of specific for mycobacterial antigens","volume":"177","author":"Caccamo","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0280","first-page":"Unit 19.5","article-title":"Animal models of mycobacteria infection","volume":"Chapter 19","author":"Orme","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0285","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/j.ijid.2012.07.008","article-title":"Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis","volume":"11","author":"You","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0290","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/IAI.73.8.5189-5193.2005","article-title":"Factors associated with severe granulomatous pneumonia in Mycobacterium tuberculosis-infected mice vaccinated therapeutically with hsp65 DNA","volume":"73","author":"Taylor","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0295","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ni.1781","article-title":"Foamy macrophages and the progression of the human TB granuloma","volume":"9","author":"Russell","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.06.037_bib0300","doi-asserted-by":"crossref","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","article-title":"Foamy macrophages from tuberculous patients granulomas constitute a nutrient rich reservoir for M. tuberculosis persistence","volume":"11","author":"Peyron","year":"2008","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14008263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T11:18:30Z","timestamp":1689333510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14008263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":60,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0264410X14008263"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.06.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}